WFRF:(Deming Y. K.)
Search: WFRF:(Deming Y. K.) > (2020-2023) > Cerebrospinal Fluid...
- 4 of 5
- Previous record
- Next record
- To hitlist
Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation
- Morrow, A. (author)
- Panyard, D. J. (author)
- Deming, Y. K. (author)
- show more...
- Jonaitis, E. (author)
- Dong, R. (author)
- Vasiljevic, E. (author)
- Betthauser, T. J. (author)
- Kollmorgen, G. (author)
- Suridjan, I. (author)
- Bayfield, A. (author)
- Van Hulle, C. A. (author)
- Carlsson, C. M. (author)
- Asthana, S. (author)
- Johnson, S. C. (author)
- Engelman, C. D. (author)
- show less...
- (creator_code:org_t)
- IOS Press, 2022
- 2022
- English.
- In: Journal of Alzheimers Disease. - : IOS Press. - 1387-2877 .- 1875-8908. ; 90:2, s. 667-680
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Background: Sphingomyelin (SM) levels have been associated with Alzheimer's disease (AD), but the association direction has been inconsistent and research on cerebrospinal fluid (CSF) SMs has been limited by sample size, breadth of SMs examined, and diversity of biomarkers available. Objective: Here, we seek to build on our understanding of the role of SM metabolites in AD by studying a broad range of CSF SMs and biomarkers of AD, neurodegeneration, and neuroinflammation. Methods: Leveraging two longitudinal AD cohorts with metabolome-wide CSF metabolomics data (n = 502), we analyzed the relationship between the levels of 12 CSF SMs, and AD diagnosis and biomarkers of pathology, neurodegeneration, and neuroinflammation using logistic, linear, and linear mixed effects models. Results: No SMs were significantly associated with AD diagnosis, mild cognitive impairment, or amyloid biomarkers. Phosphorylated tau, neurofilament light, alpha-synuclein, neurogranin, soluble triggering receptor expressed on myeloid cells 2, and chitinase-3-like-protein 1 were each significantly, positively associated with at least 5 of the SMs. Conclusion: The associations between SMs and biomarkers of neurodegeneration and neuroinflammation, but not biomarkers of amyloid or diagnosis of AD, point to SMs as potential biomarkers for neurodegeneration and neuroinflammation that may not be AD-specific.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Neurovetenskaper (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Neurosciences (hsv//eng)
Keyword
- Alzheimer's disease
- biomarkers
- cerebrospinal fluid
- metabolomics
- neurodegeneration
- neuroinflammation
- sphingolipid
- sphingomyelin
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- Journal of Alzheimers Disease (Search for host publication in LIBRIS)
To the university's database
- 4 of 5
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Morrow, A.
- Panyard, D. J.
- Deming, Y. K.
- Jonaitis, E.
- Dong, R.
- Vasiljevic, E.
- show more...
- Betthauser, T. J ...
- Kollmorgen, G.
- Suridjan, I.
- Bayfield, A.
- Van Hulle, C. A.
- Zetterberg, Henr ...
- Blennow, Kaj, 19 ...
- Carlsson, C. M.
- Asthana, S.
- Johnson, S. C.
- Engelman, C. D.
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Basic Medicine
- and Neurosciences
- Articles in the publication
- Journal of Alzhe ...
- By the university
- University of Gothenburg
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
